You are trying to get your drug to market as fast as possible, and you know you can’t rest on the innovations of the past. But how ready are you for the future and the ways in which you might need to transform?
No matter where you are on the path to clinical transformation, Covance Clinical can help. We can help address your challenges using Ingenuity4, the powerful combination of our four strengths. Discover the components of Ingenuity4 below or schedule a meeting with a representative now.
Learn more about what makes up Ingenuity4.
Solutions from Covance Clinical.
The power of Ingenuity4 runs through every product and service Covance Clinical has to offer. Below, discover more about the solutions we offer along with proof of their effectiveness.
Schedule a meeting with a representative now to learn more about Covance Clinical solutions.
See solutions from Covance Clinical.
From Covance Clinical
Covance Clinical intelligent recruitment can minimize study costs, speed time to market and increase forecasting accuracy by selecting the most ideal sites for a particular study that correspond to clusters of eligible participants. Only Covance Clinical has timely, real-world LabCorp diagnostic lab result data, global Central Labs investigator performance data and patient Intelligence input that provides unique insights that enable us to deliver faster patient enrollment and enhanced patient retention.
Discover the various solutions that deliver intelligent recruitment for your studies.
Protocol Design Tool
Our Protocol Design Tool helps us design studies with greater certainty. It allows us to understand the impact of each inclusion or exclusion criteria against the patient population to assess the number of patients that meet study criteria. It allows for proactive planning and modification of protocol criteria to maximize the patient pool with the least amount of changes – or ensures accurate planning if modifications are not possible.
Patient Intelligence Database
Our proprietary global Patient Intelligence Database provides insights that help us fit the protocol to the patient because we understand specific criteria that motivates or prevents patients from participating and completing a study.
Protocol Design Tool
Our Protocol Design Tool can pinpoint geographic clusters of people who fit a study’s eligibility criteria.
Site List Tool
Our Site List Tool identifies high performing sites and countries based on factual trial performance data in the indication or therapeutic area under evaluation.
Our direct-to-consumer recruitment model supplements investigators’ databases/records to enhance recruitment potential.
Covance Clinical inspiring science provides cutting-edge counsel and a sounding board for strategic development plans. Our scientific team is dedicated to furthering innovations in science and brings that same passion to their therapeutic areas. Discover our solutions within inspiring science, as well as our expertise by therapeutic area.
Product Development Consulting Group
This group bridges the gap between science and business to accelerate product development. Specialists, who are both scientists and experienced drug developers, guide our teams through the rapidly changing scientific and regulatory frontiers to maximize the value of an asset, extending patent life and maximizing asset value for the sponsor.
Enterprise-wide expertise in both diagnostics and drug development support any development need in the area of targeted therapy.
Dedicated Biomarker Solution Center
Our Biomarker Solution Center is a leader in biomarker applications, driving innovative precision medicine therapies.
Cell and Gene Therapy
With specialized expertise, coordinated capabilities and
focused investments across non-clinical, clinical and
post-approval phases, we can reduce the time and risk in
product development. We have supported the development of
FDA approved CAR-T therapies and helped advance the first two FDA approved gene replacement therapies.
Therapeutic Area Expertise
Covance is the leading CRO in NASH having the largest informative knowledgebase of NASH sites worldwide, including randomized and biopsy-confirmed patients, modern diagnostic test results and comprehensive clinical experience from early strategic planning to full clinical development. Our Liver Therapeutic Area Head is an internationally recognized leader in NASH clinical research and author of highly cited review articles published in prestigious scientific journals.
Rare & Pediatric
We have a unique combination of dedicated rare disease and pediatric expertise and comprehensive cross-functional operational support. We have a robust study planning team and execution strategies that anticipate regulatory hurdles and make patient centricity an integral part of the path forward to accelerate patient identification and recruitment.
We have an oncology team comprised of medical, regulatory and operational professionals with extensive drug development expertise across tumors and therapies. These include CAR-T, genomics, biomarkers, companion diagnostics and adaptive trial design.
Diabetes & Related Complications
Covance is a leading CRO with pioneering enterprise solutions in clinical development for Type I and Type II diabetes and chronic complications of diabetes including cardiovascular diseases, nephropathy and retinopathy. Our Therapeutic Area Head for diabetes and metabolic disorders is an internationally recognized endocrinologist who co-edited the recent comprehensive 5th edition of the popular Textbook of Diabetes (Wiley Blackwell).
Covance Clinical integrated delivery provides strong project leaders and a trusted team of operational professionals for reliable study conduct. Discover our various solutions within integrated delivery, as well as proof points that show our effectiveness.
Your Project Management Team
Our Project Management Center of Excellence, with roughly 1,500 project managers, is dedicated to on-time delivery of quality results within budget. We have expertise in risk mitigation strategies, and our people are empowered to own and drive their projects and make critical decisions necessary to overcome challenges.
We make trials more convenient for study subjects with wearables, patient service centers and hybrid virtual trials.
Flexible Outsourcing Models
We offer FSPx, Standalone and Full Services to meet the outsourcing needs of sponsors.
Robust Monitoring Solutions
We have six robust individual products that work together or apart to tackle risk and meaningfully improve the quality, time and cost of the clinical oversight process. These drive efficiencies in costs and resources.
Evidence-based Performance Metrics demonstrate our ability to deliver studies on time with greater efficiencies associated with our monitoring solutions.
- Achieved database lock milestones in last 8 of 8 years1
- In all phases of Oncology studies, bested our milestones by an average of 35 days1
- In all phases of Oncology studies, outperformed the market by 4.2 months faster than the industry2
- Covance Governance Records
- Site Activation to Last Patient In (Phase I-IV)
Covance Clinical illuminating data provides an unrivalled, powerful combination of data sources to drive informed decision-making. See the power of these sources.
Sources of Data
LabCorp De-Identified Data
LabCorp is one of the largest single sources of diagnostic lab data in the world. Timely, real-world diagnostic lab results data – with 30 billion test results across 5,000 assays from 150 million people in the US – can be used to identify clusters of people that meet a study’s eligibility criteria.
Global Central Labs Data
Covance generates more clinical trial data than anyone else in the world. With performance data on >50% of all global clinical trials, including 175,000 unique investigators across >50 countries we can identify the most productive investigators by indication to consider for a trial.
Patient Intelligence Database
We have insights from patients who live with a disease, covering more than 50 indications from 30 countries. This enables us to help deliver faster patient enrollment and enhanced patient retention.
Patient direct creates a direct connection to 150 million US-based people, enabling us to invite them to participate in clinical studies.
Biomarker Solution Center
Biomarkers increase the probability of approval for Phase I-IV studies. The number of clinical studies conducted that are approved using biomarkers is 25.9% vs 8.4% without.
Want to keep this information?Download a printable version of our solutions here
CONTACT US TO EXPERIENCE
Schedule a meeting with us today to do any of the following.
- Demo Protocol Design Tool
- Discuss Inspiring Science
- Discuss Integrated Delivery
- Demo Patient Intelligence Tool
Experience our intelligent recruitment with a demo of our Protocol Design Tool. Fill out the form to schedule a demo with a representative today.
Discuss how our expertise by therapeutic area and molecule can help you. Fill out the form to schedule a meeting with a representative today.
Discuss how our expertise and analytics can improve the delivery of your trials. Fill out the form to schedule a meeting with a representative today.
Experience our illuminating data with a demo of our Patient Intelligence Tool. Fill out the form to schedule a demo with a representative today.